Deficits in d-fenfluramine-sensitive pool of brain 5-HT following withdrawal from chronic cocaine exposure

Life Sciences

Volumn 61, Issue 26, 1997, Pages 2575-2582

  Darmani, Nissar A ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

5 HT(2A) receptors; Cocaine; D fenfluramine; Head twitch; Withdrawal

Indexed keywords

COCAINE; DEXFENFLURAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG WITHDRAWAL; HEAD TWITCH; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SEROTONIN BRAIN LEVEL;

ANIMALS; BRAIN; COCAINE; FENFLURAMINE; HEAD MOVEMENTS; KINETICS; MALE; MICE; MICE, INBRED ICR; SEROTONIN; SEROTONIN AGENTS; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0031454002     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)01012-6     Document Type: Article

References (52)

1. BRODERICK P.A., KORNAK E.P., ENG F., WECHLER R. Pharmacol. Biochem. Behav. 46:1993;715-722.
2. BRADBERRY C.W., NOBILETTE J.B., ELSWORTH J.D., MURPHY D., JATLOW P., ROTH R.H. J. Neurochem. 60:1993;1429-1435.
3. PARSONS L.H., JUSTICE J.B. JR. J. Neurochem. 61:1993;1611-1619.
4. PARSONS L.H., KOOB G.F., WEISS F. J. Pharmacol. Exp. Therap. 274:1995;1182-1191.
5. RITZ M.C., CONE E.J., KUHAR M.J. Life Sci. 46:1990;635-645.
6. F. WEISS, L.H. PARSONS and A. MARKOU, The Neurobiology of Cocaine: Cellular and Molecular Mechanisms, R.P. Hammer, Jr. (Ed), 163-180, CRC Press, Boca Ration, Florida (1995).
7. BAUMANN M.H., RALEY T.J., PARTILLA J.S., ROTHMAN R.B. Synapse. 14:1993;40-50.
8. DWORKIN S.I., CO C., SMITH J.E. Brain Res. 682:1995;116-126.
9. GALLOWAY M.P. Synapse. 6:1990;63-72.
10. KLEVEN M.S., WOOLVERTON W.L., SEIDEN L.S. Brain Res Bull. 21:1988;233-237.
11. SEIDEN L.S., KLEVEN M.S. Nat. Inst. Drug Abuse Mong. Ser. 88:1988;276-289.
12. YEH S.Y., DE SOUZA E.B. Drug Alcohol Depen. 27:1991;51-61.
13. DARMANI N.A. Life Sci. 61:1997;1147-1158.
14. D.J. HEAL, G.P. LUSCOMBE and K.F. MARTIN, Pharmacological Characterization of 5-HT Receptor Subtypes Using Behavioral Models, C.A. Marsden and D.J. Heal (Eds), 56-99, Blackwell Scientific Pub., London (1992).
15. SINGLETON C., MARSDEN C.A. Psychopharmacology. 74:1981;173-176.
16. N.A. DARMANI, Pharmacol. Biochem. Behav. (In press) 1997.
17. TRULSON M.E., JACOBS B.L. Eur. J. Pharmacol. 36:1976;149-154.
18. KUHN D.M., WOLF W.A., YOUDIM M.B.H. Br. J. Pharmacol. 84:1985;121-129.
19. BONANNO G., FASSIO A., SEVERI P., RUELLE A., RAITERI M. J. Neurochem. 63:1994;1163-1166.
20. RAITERI M., BONANNO G., VALLEBUONA F. J. Pharmacol. Exp. Therap. 273:1995;643-649.
21. SABOL K.E., RICHARDS J.B., SEIDEN L.S. Brain Res. 585:1992;421-424.
22. MOROT-GAUDRY Y., BOURGION S., HAMMON M. Naunyn-Schmied Arch. Pharmacol. 316:1981;311-316.
23. ADELL A., SARNA G.S., HUTSON P.H., CURZON G. Br. J. Pharmacol. 97:1989;206-212.
24. LONG J.B., YOUNGBLOOD W.Y., KIZER J.S. Eur. J. Pharmacol. 88:1983;89-97.
25. GARTSIDE S.E., COWEN P.J., SHARP T. Neuropharmacology. 31:1992;9-14.
26. GREENGARD P., VALTORTA F., CZERNIK A.J., BENFENATI F. Science. 259:1992;781-785.
27. DARMANI N.A. Life Sci. 59:1996;1109-1119.
28. DARMANI N.A., REEVES S.L. Pharmacol. Biochem. Behav. 55:1996;387-396.
29. GOBBI M., FRITTOLI E., MENNINI T., GARATTINI S. Naunyn-Schmied Arch. Pharmacol. 345:1992;1-6.
30. LEVY A.D., RITTENHOUSE P.A., LI Q, BONADONNA A.M., ALVAREZ SANZ M.C., KERR J.E., BETHA C.L. Brain Res. 580:1992;6-11.
31. LEVY A.D., RITTENHOUSE P.A., BONADONNA A.M., ALVAREZ SANZ M.D., BETHA C.L., VAN DE KAR L.D. Eur. J. Pharmacol. 241:1993;275-278.
32. VAN DE KAR L.D., BONADONNA A.M., RITTENHOUSE P.A., KERR J-E., LEVY A.D., IYER L., HERBERT G.B., ALVAREZ SANZ M.C., LENT S.J., CARNES M. Neuropharmacology. 31:1992;169-176.
33. BAUMANN M.H., BECKETTS K.M., ROTHMAN R.B. Eur. J. Pharmacol. 282:1993;87-93.
34. LEVY A.D., LI Q., VAN DE KAR L.D. Neuropharmacology. 33:1994;335-342.
35. KNAPP S., MANDEL A.J. Science. 177:1972;1209-1211.
36. K.A. CUNNINGHAM, The Neuroobiology of Cocaine: Cellular and Molecular Mechanisms, R.P. Hammer, Jr. (Ed), 121-143, CRC Press, Boca Raton, Florida (1995).
37. CUNNINGHAM K.A., PARIS J.M., GOEDERS N.E. Synapse. 11:1992;112-123.
38. DARMANI N.A., HADFIELD M.G., CARTER W.H., MARTIN B.R. Psychopharmacology. 102:1990;37-40.
39. JAVAID J.I., SAHNI S.K., PANDEY S.C., DAVIS J.M. Eur. J. Pharmacol. 238:1993;425-429.
40. JOHNSON R.G., FIORELLA D., RABIN R.A. Pharmacol. Biochem. Behav. 46:1993;289-293.
41. NEISWANDER J.L., LUCKI I., MCGONIGLE P. Synapse. 16:1994;1-10.
42. DARMANI N.A., MARTIN B.R., GLENNON R.A. Pharmacol. Biochem. Behav. 41:1992;519-527.
43. BAUMANN M.H., BROCKINGTON A.M., ROTHMAN R.B. Biol. Psychiatry. 34:1993;576-577.
44. BAUMANN M.H., ROTHMAN R.B. Neuropharmacology. 35:1996;295-301.
45. SMITH R.L., BARRET R.J., SANDERS-BUSH E. J. Pharmacol. Exp. Therap. 254:1990;484-488.
46. LOH E.A., ROBERTS D.C.S. Psychopharmacology. 101:1990;262-266.
47. ROBERTS D.C.S., LOH E.A., BAKER G.B., VICKERS G. Pharmacol. Biochem. Behav. 49:1994;177-182.
48. CARROLL ME, LAC S.T., ASENCIO M., KARGH R. Psychopharmacology (Berl.). 100:1990;293-300.
49. MCGREGOR A., LACOSTA S., ROBERTS D.C.S. Pharmacol. Biochem. Behav. 44:1993;651-655.
50. CARROLL M.E., LACK S.T., ASENCIO M., KARGH R. Pharmacol. Biochem. Behav. 35:1990;237-244.
51. GUERIN G.F., CROW C., CUNNINGHAM K.A., GOEDERS N.E. Soc. Neurosci. Abs. 18:1992;724.
52. RICHARDSON N.R., ROBERTS D.C.S. Life Sci. 49:1991;833-840.